{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:38:35Z","timestamp":1781188715643,"version":"3.54.1"},"reference-count":48,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2008,3,20]],"date-time":"2008-03-20T00:00:00Z","timestamp":1205971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Glucocorticosteroids versus placebo or no intervention for patients with alcoholic hepatitis have been evaluated for more than 35 years. However, the results of randomized trials and meta\u2010analyses differ substantially.<\/jats:p><jats:p><jats:bold>Aim\u2002<\/jats:bold> To review all randomized clinical trials of glucocorticosteroids vs. placebo or no intervention for patients with alcoholic hepatitis.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> We searched for randomized trials published before July 2007. The trials were assessed for risk of bias.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> We included 15 trials with a total of 721 randomized patients. The overall mortality rate was 39.5%. Twelve of the fifteen trials were at risk of bias. Glucocorticosteroids did not statistically reduce mortality compared with placebo or no intervention (relative risk 0.83, 95% CI 0.63\u20131.11). Glucocorticosteroids significantly reduced mortality in the subgroup of trials with patients with Maddrey\u2019s score of at least 32 or hepatic encephalopathy and with low\u2010bias risk. In all analyses, heterogeneity was significant and substantial. Trial sequential analyses using heterogeneity\u2010adjusted information size demonstrated no significant effect of glucocorticosteroids on mortality. Weighted logistic regression analyses taking prognostic factors at randomization into consideration found no significant effect of glucocorticosteroids on mortality.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The current evidence base of mainly heterogeneous with high bias risk trials does not support the use of glucocorticosteroids in alcoholic hepatitis. Large, low\u2010bias risk placebo\u2010controlled randomized trials are needed.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2008.03685.x","type":"journal-article","created":{"date-parts":[[2010,7,23]],"date-time":"2010-07-23T14:01:36Z","timestamp":1279893696000},"page":"1167-1178","source":"Crossref","is-referenced-by-count":158,"title":["Systematic review: glucocorticosteroids for alcoholic hepatitis \u2013 a Cochrane Hepato\u2010Biliary Group systematic review with meta\u2010analyses and trial sequential analyses of randomized clinical trials"],"prefix":"10.1111","volume":"27","author":[{"given":"A.","family":"RAMBALDI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. H.","family":"SACONATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"CHRISTENSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"THORLUND","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"WETTERSLEV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"GLUUD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,20]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"221","article-title":"Diagnosis and treatment of alcoholic liver disease in Europe. First report","volume":"6","author":"Gluud C","year":"1993","journal-title":"Gastroenterol Int"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.37.1.113"},{"key":"e_1_2_7_4_2","first-page":"323","volume-title":"FALK Symposium 121. Steatohepatitis (NASH and ASH)","author":"Gluud C","year":"2001"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.00587.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.06.003"},{"key":"e_1_2_7_7_2","volume-title":"Alcoholic hepatitis","author":"Mihas AA","year":"2006"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.03065.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00045-4"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520290060030"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)01085-X"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-11-200112040-00010"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.03.013"},{"key":"e_1_2_7_14_2","first-page":"102","volume-title":"12th International Cochrane Colloquium","author":"Als\u2010Nielsen B","year":"2004"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.17.2203"},{"key":"e_1_2_7_16_2","first-page":"1","volume":"3","author":"Higgins JPT","year":"2005","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001511"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90401-8"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001511"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-74-3-311"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197106172842404"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-79-5-625"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01072499"},{"key":"e_1_2_7_25_2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0016-5085(78)90814-4","article-title":"Unpublished trial. Quoted by Conn HO. Steroid treatment of alcoholic hepatitis. The yeas and the nays","volume":"74","author":"Galambos JT","year":"1978","journal-title":"Gastroenterology"},{"key":"e_1_2_7_26_2","first-page":"1100","article-title":"Risk factors and therapy in alcoholic hepatitis (AH)","volume":"72","author":"Mendenhall CL","year":"1977","journal-title":"Gastroenterology"},{"key":"e_1_2_7_27_2","first-page":"443","article-title":"A controlled trial of 6\u2010methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients","volume":"69","author":"Shumaker JB","year":"1978","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_28_2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double\u2010blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy","volume":"78","author":"Depew W","year":"1980","journal-title":"Gastroenterology"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.23.1.75"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198412063112302"},{"key":"e_1_2_7_31_2","first-page":"769","article-title":"Prednisolone treatment of alcoholic hepatitis: forty\u2010five cases","volume":"16","author":"Bories P","year":"1987","journal-title":"Presse Med"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-110-9-685"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199202203260802"},{"key":"e_1_2_7_34_2","first-page":"S75","article-title":"Influence of corticosteroids (CS) on plasma cytokines concentrations in patients with severe alcoholic hepatitis (HA): results of a randomized study","volume":"18","author":"Richardet JP","year":"1993","journal-title":"J Hepatol"},{"key":"e_1_2_7_35_2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0016-5085(78)90814-4","article-title":"Steroid treatment of alcoholic hepatitis. The yeas and the nays","volume":"74","author":"Conn HO","year":"1978","journal-title":"Gastroenterology"},{"key":"e_1_2_7_36_2","volume-title":"Liver Transplantation Program and Center for Liver Diseases","author":"Reynolds TB"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(78)90790-4"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.8627"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.3.831"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj069"},{"key":"e_1_2_7_41_2","first-page":"88","volume-title":"12th International Cochrane Colloquium","author":"Als\u2010Nielsen B","year":"2004"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39465.451748.AD"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.12.006"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)08461-4"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38503.623646.8F"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39398.682500.25"},{"key":"e_1_2_7_47_2","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1053\/gast.2001.28031","article-title":"AGA technical review on parenteral nutrition","volume":"1214","author":"Koretz RL","year":"2001","journal-title":"Gastroenterology"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.01024.x"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v12.i43.6909"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2008.03685.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2008.03685.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T10:35:43Z","timestamp":1697193343000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2008.03685.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,20]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1111\/j.1365-2036.2008.03685.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2008.03685.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,20]]}}}